These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15930161)

  • 1. Gene therapy of pituitary diseases.
    Lee EJ; Jameson JL
    J Endocrinol; 2005 Jun; 185(3):353-62. PubMed ID: 15930161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary transcription factors: from congenital deficiencies to gene therapy.
    Quentien MH; Barlier A; Franc JL; Pellegrini I; Brue T; Enjalbert A
    J Neuroendocrinol; 2006 Sep; 18(9):633-42. PubMed ID: 16879162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypopituitarism due to pituitary macroadenoma in an older person: an unusual presentation.
    Ahmed IM; Kannappan H; Datta-Chaudhuri M; Rauf O
    J Am Geriatr Soc; 2008 Jan; 56(1):172-3. PubMed ID: 18184211
    [No Abstract]   [Full Text] [Related]  

  • 5. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.
    Voutetakis A; Bossis I; Kok MR; Zhang W; Wang J; Cotrim AP; Zheng C; Chiorini JA; Nieman LK; Baum BJ
    J Endocrinol; 2005 Jun; 185(3):363-72. PubMed ID: 15930162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for cancer gene therapy.
    Hughes RM
    J Surg Oncol; 2004 Jan; 85(1):28-35. PubMed ID: 14696084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopituitarism oddities: craniopharyngiomas.
    Karavitaki N
    Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for pituitary tumors.
    Seilicovich A; Pisera D; Sciascia SA; Candolfi M; Puntel M; Xiong W; Jaita G; Castro MG
    Curr Gene Ther; 2005 Dec; 5(6):559-72. PubMed ID: 16457646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice.
    Sagazio A; Xiao X; Wang Z; Martari M; Salvatori R
    J Endocrinol; 2008 Jan; 196(1):79-88. PubMed ID: 18180319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of catheter- and stent-based gene therapy.
    Sharif F; Daly K; Crowley J; O'Brien T
    Cardiovasc Res; 2004 Nov; 64(2):208-16. PubMed ID: 15485679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
    Losa M; Gatti E; Rossini A; Lanzi R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of replication-incompetent HSV-1-based vectors.
    Berto E; Bozac A; Marconi P
    Gene Ther; 2005 Oct; 12 Suppl 1():S98-102. PubMed ID: 16231061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pituitary gland.
    Strong JA
    Clin Endocrinol Metab; 1980 Nov; 9(3):605-14. PubMed ID: 7214738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.